American HealthCare Capital provides sellers with comprehensive representation guiding them through each step of the sale process. We develop individualized exit strategy’s and work closely with each seller to ensure a smooth and successful transaction that maximizes the value of the assets. Our fee is reasonable and applies only when a transaction is successfully completed.

Our process starts with a confidential analysis and valuation. We will discuss what data is necessary and what format is preferred. Once we have established a fair market asking price, we write a “blind” executive summary that is designed to highlight key value drivers while intentionally concealing the identity of the seller. The executive summary is used to profile the opportunity to qualified prospective buyers before they sign a confidentiality agreement.

We only execute confidentiality agreements with prospective buyers who are both operationally and financially qualified: buyers who are capable of running the business and who have the financial resources to close a transaction. After a confidentiality agreement is executed, we provide a brief information summary to prospective buyers as a basis for further discussion about the opportunity. In order to protect the confidentiality of the seller, greater detail about the seller is only provided on an as-needed basis as required by prospective buyers who wish to offer a letter of intent.